Biartrin - instructions for use, analogs, reviews and release forms (injections in ampoules for injection in a solution of 1 ml) drugs for the treatment of arthrosis, spondylosis, patellar chondromalation in adults, children and pregnancy. Composition

In this article, you can read the instructions for using the drug Biartrin. Presented are reviews of visitors to the site - consumers of this medication, as well as opinions of doctors of specialists on the use of Biartrin in his practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues of Biartrin with available structural analogues. Use for the treatment of arthrosis, spondylosis, chondromalacia of the patella in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Biartrin - a combined preparation of animal origin, contains a glycosaminoglycan-peptide complex (active ingredient Biartrin). The effect of the drug is due to the combined effect of its active components. Normalizes metabolism in cartilaginous hyaline tissue: enhances the biosynthesis of sulfated mucopolysaccharides and collagen, stimulates the regeneration of articular cartilage, reduces the activity of enzymes and inhibits catabolic processes in the cartilaginous tissue.

Composition

Glycosaminoglycan-peptide complex + auxiliary substances.

Indications

Degenerative and dystrophic joint diseases:

• gonarthrosis (arthrosis of the knee joint);
• arthrosis of interphalangeal joints;
• Coxarthrosis (arthrosis of the hip joint);
• spondylosis (deformity of the vertebrae);
• spondylarthrosis;
• meniscopathy (knee joint meniscus pathology);
• chondromalacia of the patella (destruction of the cartilage of the posterior surface of the patella);
• polyarthrosis (arthrosis of several joints);
• other arthrosis.

Forms of release

Solution for intramuscular injection 1 ml (injections in ampoules for injection).

Instructions for use and dosing regimen

Intramuscularly.

The drug is administered intramuscularly: on the first day - 0.3 ml, on the second day - 0.5 ml, then - 1 ml (1 ampoule) 3 times a week for 5-6 weeks. Repeated course of treatment - after consultation with a doctor according to the same scheme.

Side effect

• allergic reactions (rarely);
• anaphylactoid reactions, including anaphylactic shock.

If any of the side effects indicated in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

Contraindications

• hypersensitivity to the components of the drug;
• rheumatoid arthritis;
• pregnancy and lactation;
• age to 18 years;
• Use in women of reproductive age not observing reliable methods of contraception.

Application in pregnancy and lactation

Data on the use of Biartrin during pregnancy and during breastfeeding are absent. Application in pregnancy and lactation is not recommended.

Women of reproductive age during the treatment with the drug must comply with reliable methods of contraception.

Use in children

The drug is contraindicated in children and adolescents under the age of 18 years.

special instructions

When used simultaneously with indirect anticoagulants, antiplatelet agents, fibrinolytic drugs, frequent monitoring of blood clotting parameters is necessary.

Impact on the ability to drive vehicles and manage mechanisms

Information about the effect on the ability to drive vehicles and work with mechanisms that require an increased speed of psychomotor reactions, no.

Drug Interactions

It can be used simultaneously with non-steroidal anti-inflammatory drugs and glucocorticosteroids. When used simultaneously with indirect anticoagulants, antiplatelet agents and fibrinolytic agents, their effect may be enhanced.

Analogues of the Biartrin drug

Structural analogs for the active substance:

• Rumalon.

Analogues on the pharmacological group (correctors of bone and cartilage tissue metabolism):

• Adelon;
• Aklast;
• Alendronate;
• Alflutop;
• Alfadol;
• Artogistan;
• Artradol;
• Arthrakam;
• Arthra;
• Arthrin;
• Bivalos;
• Blazter;
• Bonviva;
• Bonefos;
• Van Alpha;
• Veprena;
• Veroclast;
• Videchol;
• Gialripayer 02;
• Gialripayer 10;
• Glucosamine;
• Don;
• The Drastop;
• Zoledronate;
• Zoledrax;
• Intragel
• Calcitonin;
• Klobir;
• Xidifon;
• Miakaltsik;
• Mukosat;
• Sodium fluoride;
• Ossin;
• Ostalon;
• Osteover;
• Osteogenon
• Pimegar;
• Prolia;
• Resorb;
• Rizarteva;
• Rockaltrol;
• Rumalon;
• Sinoarth;
• Skelid;
• Strometta;
• Stringos;
• Structum;
• Sustilac;
• Tahistin;
• Tevanath;
• Tridin;
• Fitin;
• Forosa;
• Forste;
• Fosamax;
• Chondraktiv;
• Chondramine;
• Chondroitin;
• Chondroxide;
• Chondrolon;
• Exidgiva;
• Elbon;
• Ethalph;
• The Unium.

Response of a rheumatologist

Biartrin I prescribe to patients with degenerative-dystrophic joint diseases. A good therapeutic effect is noted in the treatment of arthrosis of the knee and hip joints, with the involvement of interphalangeal joints of the fingers. After the first one and a half month course, the patients note an improvement in their well-being - pains in the joints are passing, and the stiffness of movements disappears. In my practice, there were no cases when one of the patients complained of any adverse reactions to the administration of the drug.

Similar medicines:

Other medicines: